| 摘要 |
<p>The use of ketoconazole or molecules resembling ketoconazole but with some side-chains, not affecting the biological activity compared to ketoconazole, changed, for the manufacture of drugs for medical treatment of diabetes mellitus type II as well as for counteracting the other risk factors being part of the Metabolic Syndrome (also known as 'the deadly quartet' or 'Syndrome X' or the 'Insulin Resistance Syndrome').</p> |
